China Longyi Group International Holdings Ltd CGYG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
China Longyi Group International Holdings Ltd is a holding company. Through its subsidiaries, it principally develops, manufactures and markets Superoxide Dismutase (SOD) products. SOD has applications in foods, drinks, skin care productions, pharmaceuticals, to combat ailments ranging from sunburn to rheumatoid arthritis. It produces and sells SOD Lifeblood which is a mixture of SOD and Enzymes as an antioxidant. The group primarily generates revenue from marketing its products in China.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 47
- Website
- http://www.allsod.com
Valuation
|
Metric
|
CGYG
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
CGYG
Financial Strength
|
Metric
|
CGYG
|
|---|---|
Quick Ratio | 0.05 |
Current Ratio | 0.27 |
Interest Coverage | −97.60 |
Quick Ratio
CGYG
Profitability
|
Metric
|
CGYG
|
|---|---|
Return on Assets (Normalized) | −48.31% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
CGYG
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qgbs | $456.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Mzmch | $91.4 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Wsjzdv | $89.8 Bil | |
SGEN
| Seagen Inc Ordinary Shares | Kxrktn | $40.2 Bil | |
MRNA
| Moderna Inc | Vvkc | $29.6 Bil | |
ARGX
| argenx SE ADR | Xzgw | $26.4 Bil | |
BNTX
| BioNTech SE ADR | Zpl | $23.9 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Rplzth | $21.1 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Vstwf | $17.2 Bil | |
INCY
| Incyte Corp | Knyhdqt | $12.2 Bil |